We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > small cell

News List

Roche’s Tecentriq gets FDA priority review to treat small cell lung cancer pharmaceutical-technology
December 10, 2018
The US Food and Drug Administration (FDA) has granted priority review for Roche’s Tecentriq (atezolizumab) in combination with chemotherapy for treating extensive-stage small cell lung cancer (ES – SCLC).....
Roche's marketing application for Tecentriq in small cell lung cancer gets FDA priority review firstwordpharma
December 05, 2018
Roche said Wednesday that the FDA granted priority review to a marketing application seeking approval of Tecentriq (atezolizumab), in combination with chemotherapy, for the initial treatment of people with extensive-stage small cell lung cancer (SCLC). Th